Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.
Department of Psychiatry and Biobehavioral Sciences, Institute for Society and Genetics, UCLA, Los Angeles, CA, USA.
J Genet Couns. 2022 Feb;31(1):59-70. doi: 10.1002/jgc4.1451. Epub 2021 Jun 11.
The Genome Empowerment Scale (GEmS), developed as a research tool, assesses perspectives of parents of children with undiagnosed disorders about to undergo exome or genome sequencing related to the process of empowerment. We defined genomic healthcare empowerment as follows: perceived ability to understand and seek new information related to the genomic sequencing, manage emotions related to the diagnostic process and outcomes, and utilize genomic sequencing information to the betterment of the individual/child and family. The GEmS consists of four scales, two are primarily emotion-focused (Meaning of a Diagnosis, and Emotional Management of the Process) and two are action-oriented (Seeking Information and Support, and Implications and Planning). The purpose of this research was to provide a strategy for interpreting results from the GEmS and present illustrative cases. These illustrations should serve to facilitate use of the GEmS in the clinical and research arena, particularly with respect to guiding genetic counseling processes for parents of children with undiagnosed conditions.
基因组赋权量表(GEmS)是作为研究工具开发的,用于评估即将接受外显子组或基因组测序的儿童的未确诊疾病的父母对赋权过程的看法。我们将基因组医疗保健赋权定义为:理解和寻求与基因组测序相关的新信息、管理与诊断过程和结果相关的情绪、以及利用基因组测序信息改善个体/孩子和家庭的能力。GEmS 由四个量表组成,两个主要是关注情绪的(诊断的意义和过程中的情绪管理),两个是面向行动的(寻求信息和支持,以及影响和规划)。本研究的目的是提供一种解释 GEmS 结果的策略,并展示说明性案例。这些示例应有助于在临床和研究领域中使用 GEmS,特别是在指导有未确诊疾病的儿童的父母的遗传咨询过程方面。